| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 43,131 | 62,239 | 63,022 | 118,169 | | Cost of Revenue | 48,000 | 63,381 | 67,277 | 109,663 | | | Gross Profit | (4,869) | (1,142) | (4,255) | 8,506 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,551 | 4,857 | 4,986 | 6,498 | | Non Recurring |
-
| 2,539 | (919) | (382) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,420) | (8,538) | (8,322) | 2,390 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (120) | 48 | 224 | (82) | | Earnings Before Interest And Taxes | (6,540) | (8,490) | (8,098) | 2,308 | | Interest Expense | 741 | 569 | 818 | 1,325 | | Income Before Tax | (7,281) | (9,059) | (8,916) | 983 | | Income Tax Expense | (2,226) | (2,826) | (2,782) | 695 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,055) | (6,233) | (6,134) | 288 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,055) | (6,233) | (6,134) | 288 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,055) | ($6,233) | ($6,134) | $288 |
|
0.40% Nasdaq 
Income Statement
